Cargando…

Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma

The progression of non-alcoholic fatty liver disease (NAFLD), the most common liver disease, leads to non-alcoholic steatohepatitis and hepatocellular carcinoma. Despite the increasing incidence and prevalence of NAFLD, its therapeutic and preventive strategies to lower the disease burden is limited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Seogsong, Shin, Woo-Young, Oh, Yun Hwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069645/ https://www.ncbi.nlm.nih.gov/pubmed/37020584 http://dx.doi.org/10.3389/fendo.2023.1150360

Ejemplares similares

Editorial: The NAFLD-MAFLD conundrum
por: Dalbeni, Andrea, et al.
Publicado: (2023)

NAFLD‐related hepatocellular carcinoma: The growing challenge
por: Shah, Pir Ahmad, et al.
Publicado: (2023)

Major roles of kupffer cells and macrophages in NAFLD development
por: Park, Soo-Jeung, et al.
Publicado: (2023)

Peripheral blood mononuclear cell mitochondrial copy number and adenosine triphosphate inhibition test in NAFLD
por: Lee, A-Hyeon, et al.
Publicado: (2022)

Crucial role of T cells in NAFLD-related disease: A review and prospect
por: Mao, Tianyu, et al.
Publicado: (2022)

METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy
por: Pan, Yasi, et al.
Publicado: (2023)

Sensitivity to Thyroid Hormone Indices Are Closely Associated With NAFLD
por: Lai, Shuiqing, et al.
Publicado: (2021)

Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes
por: Abu-Farha, Mohamed, et al.
Publicado: (2022)

Serum metabolomic profiling unveils distinct sex-related metabolic patterns in NAFLD
por: Fotakis, Charalambos, et al.
Publicado: (2023)

The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma
por: Zhang, Chunye, et al.
Publicado: (2021)

Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma
por: Enooku, Kenichiro, et al.
Publicado: (2019)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

The role of FOXA family transcription factors in glucolipid metabolism and NAFLD
por: Yu, Chuchu, et al.
Publicado: (2023)

Editorial: Secreted proteins as novel biomarkers and therapeutic targets in NAFLD
por: Xiong, Xuelian
Publicado: (2023)

Comparative Study of Different Diets-Induced NAFLD Models of Zebrafish
por: Chen, Bo, et al.
Publicado: (2018)

Human Genetics to Identify Therapeutic Targets for NAFLD: Challenges and Opportunities
por: Du, Xiaomi, et al.
Publicado: (2021)

Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China
por: Wang, Yuying, et al.
Publicado: (2022)

Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model
por: Niu, Shu, et al.
Publicado: (2022)

Identification of ribosomal protein family as immune-cell-related biomarkers of NAFLD by bioinformatics and experimental analyses
por: Li, Gerui, et al.
Publicado: (2023)

Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinoma
por: Nahon, Pierre, et al.
Publicado: (2020)

Hunger & satiety signals: another key mechanism involved in the NAFLD pathway
por: López-Méndez, Iván, et al.
Publicado: (2023)

Comprehensive Transcriptome Profiling of NAFLD- and NASH-Induced Skeletal Muscle Dysfunction
por: Guo, Mingwei, et al.
Publicado: (2022)

Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD
por: Inagaki, Takeshi
Publicado: (2015)

Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides
por: Kořínková, L., et al.
Publicado: (2020)

Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
por: Zhang, Chunye, et al.
Publicado: (2021)

Prevalence of the Absence of Cirrhosis in Subjects with NAFLD-Associated Hepatocellular Carcinoma
por: Castellana, Marco, et al.
Publicado: (2021)

Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index–related parameters
por: Xue, Yan, et al.
Publicado: (2022)

Role of NAFLD on the Health Related QoL Response to Lifestyle in Patients With Metabolic Syndrome: The PREDIMED Plus Cohort
por: Martínez-Urbistondo, Diego, et al.
Publicado: (2022)

Exploration of the core gene signatures and mechanisms between NAFLD and sarcopenia through transcriptomic level
por: Xu, Ziying, et al.
Publicado: (2023)

Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD
por: Zhang, Ziqi, et al.
Publicado: (2023)

Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD
por: Poss, Annelise M., et al.
Publicado: (2020)

Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
por: Lian, Jingxuan, et al.
Publicado: (2021)

Circulating Ism1 Reduces the Risk of Type 2 Diabetes but not Diabetes-Associated NAFLD
por: Wang, Jiajia, et al.
Publicado: (2022)

Corrigendum: Role of NAFLD on the health related QoL response to lifestyle in patients with metabolic syndrome: The PREDIMED plus cohort
por: Martínez-Urbistondo, Diego, et al.
Publicado: (2023)

FRI591 Association Of TSH Levels And NAFLD Severity In Children And Adolescents
por: Untalan, Matthew, et al.
Publicado: (2023)

Clinical features and metabolic complications for non-alcoholic fatty liver disease (NAFLD) in youth with obesity
por: Barbieri, Emiliano, et al.
Publicado: (2023)

Global publication trends and research hotspots of the gut-liver axis in NAFLD: A bibliometric analysis
por: Yang, Shuangjie, et al.
Publicado: (2023)

Causal association of NAFLD with osteoporosis, fracture and falling risk: a bidirectional Mendelian randomization study
por: Cui, Aiyong, et al.
Publicado: (2023)

Increased plasma genistein after bariatric surgery could promote remission of NAFLD in patients with obesity
por: Wang, Geng, et al.
Publicado: (2023)

Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
por: Lian, Jingxuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_84qtm4qj9pfpgrfi6n20l7oouv